TYVASO DPI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TYVASO DPI, covering 2022-05-23 to 2022-05-23. Get the full timeline:
Most recent: FDA Approved: TYVASO DPI — Original Application (United Therapeutics Corporation)